Amundi - SANA BIOTECHNOLOGY INC ownership

SANA BIOTECHNOLOGY INC's ticker is SANA and the CUSIP is 799566104. A total of 119 filers reported holding SANA BIOTECHNOLOGY INC in Q4 2022. The put-call ratio across all filers is 7.25 and the average weighting 0.1%.

Quarter-by-quarter ownership
Amundi ownership history of SANA BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$26,401
-44.5%
7,8810.0%0.00%
Q2 2023$47,601
+86.4%
7,8810.0%0.00%
Q1 2023$25,534
-78.7%
7,881
-71.2%
0.00%
Q4 2022$120,019
+144.9%
27,339
+246.9%
0.00%
Q3 2022$49,000
-44.9%
7,881
-22.8%
0.00%
Q1 2022$89,00010,2090.00%
Other shareholders
SANA BIOTECHNOLOGY INC shareholders Q4 2022
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 34,239,018$220,158,0008.29%
Crestline Management, LP 3,365,624$21,641,0002.82%
Omega Fund Management, LLC 843,750$5,425,0001.73%
Alphabet Inc. 2,812,500$18,084,0000.98%
HARVARD MANAGEMENT CO INC 468,749$3,014,0000.35%
PUBLIC SECTOR PENSION INVESTMENT BOARD 6,400,000$41,152,0000.35%
PFM Health Sciences, LP 952,733$6,126,0000.23%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 156,254$1,005,0000.20%
Viewpoint Capital Management LLC 23,545$151,0000.14%
Artal Group S.A. 400,000$2,572,0000.14%
View complete list of SANA BIOTECHNOLOGY INC shareholders